Pharma Focus Asia

Bio-Techne and Cell Signalling Technology Announce Partnership

Wednesday, February 15, 2023

Bio-Techne Corporation and Cell Signalling Technology (CST) announced the addition of Simple Western™ validation to CST antibodies. This will allow researchers in various disciplines an easier way to study important molecular signalling pathways on a trusted and validated platform. Obtaining accurate data efficiently and fast is key to advancing drug discovery and development.

This ongoing partnership will allow for an expanded menu of Simple Western validated antibodies for various targets across multiple disciplines.

This partnership with Cell Signalling Technology combines the strengths of the respective companies to provide researchers with new, more quantitative ways to interrogate signalling pathways. The assay optimisation efforts completed for this additional antibody catalogue will help scientists get groundbreaking results even faster.

magazine-slider-imageMFA + MMA 2024CPHI Chine || PMEC China 2024Asia Healthcare Week 2024Advance DoE WorkshopNitrosamine Advance Workshop 2024CPHI Korea 2024CHEMICAL INDONESIA 2024INALAB 2024 Thermo Scientific - DynaDrive and DynaSpinDigital Health Asia 2024Rehab Expo 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Pharmaceutical Manufacturing & Quality Conference2024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals ConferencePharma Quality Excellence Awards 20244th Annual Pharma GMP Quality Management 20243rd World ADC Asia 2024LogiPharma Asia 2024